Bigul

Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement Pursuant to Regulation 47 of SEBI LODR Regulations, 2015
07-05-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Corporate Action-Board approves Dividend

the Board of Directors of the Company at its meeting held today i.e. May 06, 2022 has recommended final dividend of Rs. 0.50/- per share of Rs. 10/- each (face value) for the year ended March 31, 2022 subject to approval of members in ensuing Annual General Meeting.
06-05-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Audited Financial Results For The Quarter And Year Ended On March 31, 2022

Audited Financial Results for the quarter and year ended on March 31, 2022
06-05-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Remedies Ltd 2CINL24230GJ1995PLC025661 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.59 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: SUNNYKUMAR NARWANI Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: investors@ganeshremedies.com Name of the Chief Financial Officer: SURESHBHAI DALSUKHBHAI PANCHAL Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@ganeshremedies.com Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Board to consider Final Dividend

Shree Ganesh Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 06, 2022, inter-alia, to consider the following :1. The Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2022 along with the Audit Report for the corresponding period.2. Recommendation of Final Dividend on the Equity Shares, if any.In accordance to the Code of Conduct of the Company for prohibition of insider trading, the "Trading Window" for dealing / trading in the shares of the Company was closed from April 01, 2022 and shall remain closed till 48 hours from theclosure of the Board Meeting.
27-04-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Board Meeting Intimation for Consideration Of Audited Financial Results Of The Company

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2022 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2022 along with the Audit Report for the corresponding period. 2. Recommendation of Final Dividend on the Equity Shares, if any
27-04-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 For Year Ended On March 31, 2022.

Certificate under Regulation 40 (9) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for year ended on March 31, 2022.
21-04-2022
Bigul

Shree Ganesh Remedies Ltd - 540737 - Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended On March 31, 2022

Compliance Certificate Pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended on March 31, 2022
19-04-2022
Next Page
Close

Let's Open Free Demat Account